SUSAN J. BLALOCK, Ph.D. Curriculum Vitae › wp-content › uploads › sites › ...Ferreri S, Roth MT, Casteel C, Demby KB, Blalock SJ. Methodology of an ongoing, randomized controlled

BLALOCK

1

SUSAN J. BLALOCK, Ph.D.

Curriculum Vitae

May 2012

PERSONAL DATA

Office Address:

Pharmaceutical Outcomes and Policy

UNC Eshelman School of Pharmacy,

Kerr Hall, CB# 7360

University of North Carolina

Chapel Hill, NC 27599-7573

Phone: 919-962-0080

Email: [email protected]

Home Address:

32 Mossy Lane

Pittsboro, NC 27312

Phone: 919-933-5683

EDUCATION

University of North Carolina at Chapel Hill

Department of Health Behavior and Health Education

School of Public Health

Ph.D. 1987

University of Michigan, Ann Arbor



M.P.H. 1980

University of Michigan, Ann Arbor

College of Pharmacy

B.S.Pharm. 1976

CURRENT APPOINTMENTS


Eshelman School of Pharmacy

Professor

Division of Pharmaceutical Outcomes and Policy

January 2012-Present



Vice Chair


January 2011-Present



Associate Professor


July 2002-January 2012

BLALOCK

2



Adjunct Instructor


November 2003-Present

PREVIOUS PROFESSIONAL EXPERIENCE

1998-2002: Associate Professor, Department of Pharmacy Practice, Thomas J. Long School

of Pharmacy and Health Sciences, University of the Pacific, Stockton, CA.

1996-1998: Research Associate Professor, Department of Health Behavior and Health

Education, School of Public Health, University of North Carolina, Chapel Hill, NC.

1994-1998: Research Associate, Thurston Arthritis Research Center, School of Medicine,

University of North Carolina, Chapel Hill, NC.

1994-1996: Research Assistant Professor, Department of Health Behavior and Health


1992-1998: Director, Numerical Sciences Core, Thurston Arthritis Research Center,

University of North Carolina, Chapel Hill, NC.

1987-1994: Adjunct Assistant Professor, Department of Health Behavior and Health


1987-1994: Assistant Director for Education, Department of Physical Medicine and

Rehabilitation, School of Medicine, University of North Carolina, Chapel Hill, NC.

1985-1987: Arthritis Health Professions Trainee, Department of Health Behavior and

Health Education, School of Public Health, University of North Carolina, Chapel Hill,

NC.

1982-1985: Research Assistant, Department of Health Behavior and Health Education,

School of Public Health, University of North Carolina, Chapel Hill, NC.

1981: Health Education Intern, Veterans Administration Medical Center, Ann Arbor, MI.

1980: Research Assistant, Departments of Epidemiology and Community Health, School of

Public Health, University of Michigan, Ann Arbor, MI.

1976-1989: Pharmacist, Community Pharmacy Practice.

HONORS

Longs Fellowship, University of the Pacific, 2001

Clifford M. Clarke Science Award for top ranked clinical science grant application (of 41

reviewed), National Arthritis Foundation, 2000

Rho Chi (Pharmacy Honor Society), Inducted 1999

Bernard G. Greenberg Award for Excellence in Doctoral Research from the School of Public

Health, University of North Carolina at Chapel Hill, 1988

Arthritis Health Professions Traineeship, 1985-87

Delta Omega (Public Health Honor Society), Inducted 1985

BLALOCK

3

BIBLIOGRAPHY

Book Chapters

Blalock SJ, Sleath B. Risk Evaluation and Communication. In Strom BL, Kimmel SE,

Hennessey S, eds. Pharmacoepidemiology, 5th

ed. Oxford: Wiley & Sons, 2012.

Blalock SJ, Keller S. Consumer Assessment of Pharmacy Quality. In Warholak TL, Nau

DP, eds. Pharmacy Quality: Improving the Safety and Effectiveness of Pharmacy

Services. London: McGraw-Hill; 2010.

Blalock SJ, Beard AJ, Dusetzina SB. Individual/Interpersonal Models of Health and Illness

Behavior. In Rickles NM, Wertheimer AI, Smith M, eds. Social and Behavioral

Aspects of Pharmaceutical Care, 2nd

. Edition. Sudbury, MA: Jones and Bartlett, 2010.

DeVellis RF, Blalock SJ. Outcomes of Self-Management Interventions. In Newman S,

Steed E, Mulligan K eds. Chronic Physical Illness: Self-Management and Behavioural

Interventions. London: McGraw-Hill; 2008.

Weinstein ND, Sandman PM, Blalock SJ. The Precaution Adoption Process Model. In

Glanz K, Rimer BK, Lewis FM, eds. Health Behavior and Health Education: Theory,

research and practice. San Francisco: Jossey-Bass; 2008:123-147.

DeVellis BM, Revenson TA, Blalock SJ. Rheumatic disease and women's health. In:

Gallant S, Keita GP, Royak-Schaler R, eds. Health Care for Women: Psychological,

Social and Behavioral Influences. Washington DC: American Psychological

Association Press; 1997:333-347.

DeVellis RF, Blalock SJ. Psychological and educational interventions to reduce

arthritisdisability. In: Newman S, Shipley M, eds. Clinical Rheumatology (Vol 7):

Psychological Aspects of Rheumatic Disease. London: Bailliere Tindall; 1993:397-416.

Refereed Papers (80 total, including in press)

Blalock SJ, Roberts AW, Lauffenburger JC, Thompson T, O’Connor SK. The effect of

community pharmacy-based interventions on patient health outcomes. Med Care Res

Rev, in press

Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines, RCM, Coker-

Schwimmer EJL, Rosen DL, Sista P, Lohr KN. Interventions to improve adherence to

self-administered medications for chronic diseases: a systematic review. Ann Int Med,

in press

Elstad EA, Carpenter DM, DeVellis RF, Blalock SJ. Patient decision making in the face of

conflicting medication information. Int J Qual Stud Health Well-being, in press.

Carpenter SM, Blalock SJ, DeVellis RF. Do patients with a rare disease use pharmacists for

medication information? J Am Pharm Assoc, in press

Carpenter DM, Elstad EA, Blalock S, DeVellis RF. Conflicting medication information:

Prevalence, sources and relationship to medication adherence. J Health Commun, in

press.

Blalock SJ, Keller S, Nau D, Frentzel EM. Development of the Consumer Assessment of

Pharmacy Services survey. J Am Pharm Assoc, 2012;52(3):324-32. PMID: 22618972

BLALOCK

4

Sleath BL, Blalock SJ, Stone JG, Skinner AC, Covert D, Muir K, Robin AL. Validation of a

Short Version of the Glaucoma Medication Self-Efficacy Questionnaire. Br J

Ophthalmol, 2012;92(2):258-62. PMID: 21610264

Cox WC, Smith H, Blalock SJ. Predictors of academic difficulty in a Doctor of Pharmacy

program. Int J Pharm Education, 2012;8(1). Available at:

http://www4.samford.edu/schools/pharmacy/ijpe/sp012/sp12.html

Casteel C, Blalock SJ, Ferreri S, Roth MT, Demby KB. Implementation of a community

pharmacy-based falls prevention program. Am J Geriatr Pharmacother, 2011;9(5):310-

9. PMID: 21925959

Sleath B, Blalock SJ, Covert D, Stone JL, Skinner AC, Muir K, Robin AL. The relationship

between glaucoma medication adherence, eye drop technique, and visual field defect

severity. Ophthalmol, 2011;118(12):2398-402. PMID: 21856009

Patterson ME, Blalock SJ, Smith AJ, Murray MD. Associations between prescription

copayment levels and beta-blocker medication adherence in commercially insured

heart failure patients 50 years and older. Clin Ther, 2011;33(5):608-16. PMID:

21665045

Blalock SJ. The theoretical basis for practice-relevant medication use research: patient-

centered/behavioral theories. Res Soc Adm Pharm, 2011;7(4):317-29. PMID:21272552

Aljadhey H, Tu W, Hansen RA, Blalock SJ, Brater DC, Murray MD. Risk of hyperkalemia

asssociated with selective cox-2 inhibitors. Pharmacoepidemiol Drug Saf,

2010;19(11)1194-1198

Blalock SJ, Casteel C, Roth MT, Ferreri S, Demby KB, Shankar V. Impact of enhanced

pharmacologic care on the prevention of falls: a randomized, controlled trial. Am J

Geriatr Pharmacother 2010;8(5):428-440.

Farley JB, Wang C, Blalock SJ. The status of Ph.D. education in economic, social, and

administrative sciences between 2005 and 2008. Am J Pharm Educ 2010;74(7):126

Blalock SJ, Demby KB, McCulloch KD, Stevens JA. Factors influencing hip protector use

among community-dwelling older adults. Injury Prevention 2010;16(4):235-9.

Sleath B, Blalock SJ, Robin A, Hartnett ME, Covert D, DeVellis B, Giangiacomo A.

Development of an instrument to measure glaucoma medication self-efficacy and

outcome expectations. Eye, 2010;24(4):624-631.

Beard AJ, Sleath B, Blalock SJ, Roth M, Weinberger M, Tudor G, Chewning B. predictors

of rheumatoid arthritis patient-physician communication about medication costs during

visits to rheumatologists. Arthritis Care Res, 2010;62(5):632-9.

Hansen RA, Chin H, Blalock SJ, Joy MS. Pre-dialysis chronic kidney disease: evaluation of

quality of life in clinic patients receiving comprehensive anemia care. Res Soc Adm

Pharm, 2009;5(2):143-53.

Sleath B, Blalock SJ, Bender DE, Murray M, Cerna A, Cohen MG. Latino patients'

preferences for medication information and pharmacy services. J Am Pharm Assoc

2009;49(5):632-6.

Blalock SJ, Gregory, PJ, Patel, RA, Norton LL, Callahan LF, Jordan JM. Factors associated

with potential medication-herb/natural product interactions in a rural community.

Altern Ther Health Medicine, 2009;15(5):26-34.

Farley JF, Blalock SJ. Trends and determinants of prescription anti-osteoporosis medication

Use. Am J Health Syst Pharm, 2009; 66(13):1191-201.

BLALOCK

5

Joyner PU, Thomason TE, Blalock SJ. Practice settings, job responsibilities, and job

satisfaction of nontraditional PharmD and BS pharmacy graduates. Am J Pharm Educ.

2009; 73(2):33.

Sleath B, Blalock SJ, Bender D, Murray M, Cerna A, Cohen MG. Latino’ sources of

medication and medication information in the United States and their home countries.

Patient Educ Couns. 2009; 75(2):279-82.

Blalock SJ, Demby KB, McCulloch KL, Stevens JA. Seniors’ perceptions of using hip

protectors to reduce fracture risk. J Am Geriatr Soc. 2008:56:1773-1774.

Ferreri S, Roth MT, Casteel C, Demby KB, Blalock SJ. Methodology of an ongoing,

randomized controlled trial to prevent falls through enhanced pharmaceutical care. Am J

Geriatr Pharmacother. 2008;6: 61-81.

Farley JF, Blalock SJ, Kline RR. Effect of the women’s health initiative on prescription

anti-osteoporosis medication utilization. Osteoporos Int. 2008,19:1603-1612.

Thorpe CT, DeVellis RF, Blalock SJ, Hogan SL, Lewis MA, DeVellis BM. Patients’

perceptions about illness self-management in anca-associated small vessel vasculitis.

Rheumatology 2008; 47(6):881-6

Joyner PU, Cox WC, White-Harris C, Blalock SJ. The structured interview and interviewer

training in the admissions process. Am J Pharm Educ. 2007;71:83.

Thorpe CT, DeVellis RF, Lewis MA, Blalock SJ, Hogan S, DeVellis BM. Development and

initial evaluation of a measure of self-management for adults living with anca-

associated small vessel vasculitis. Arthritis Rheum. 2007;5:1296-1302.

Blalock SJ. Predictors of calcium intake patterns: a longitudinal analysis. Health Psychol.

2007;26(3):251-258. Thorpe JM, Sleath BL, Kalinowski CT, VanHoutven CH, Blalock SJ, Landerman LR,

Campbell WH, Clipp EC. Caregiver psychological distress as a barrier to vaccination for influenza among community-dwelling elderly with dementia. Med Care. 2006;44(8):713-21.

Hansen RA, Greene SB, Williams CE, Blalock SJ, Crook KD, Akers R, Carey TS. Types of

medications errors in North Carolina nursing homes: a target for quality improvement.

Am J Geriatr Pharmacother. 2006;4(1):52-61.

Blalock SJ. Toward a better understanding of calcium intake: behavioral change

perspectives. J Reprod Med. 2005;50:901-6.

Blalock SJ, Byrd JE, Hansen RA, Yamanis TJ, McMullin K, DeVellis BM, DeVellis RF,

Panter AT, Kawata AK, Watson, LC, Jordan JM. Factors associated with potentially

inappropriate drug utilization in a sample of community-dwelling older adults. Am J

Geriatr Pharmacother. 2005;3:168-179.

Blalock SJ, Norton LL, Patel RA, Dooley MA. Patient knowledge, beliefs, and behavior

concerning the prevention and treatment of glucocorticoid-induced osteoporosis.

Arthritis Care Res. 2005;53:732-739.

Welch AC, Ferreri SP, Blalock SJ, Caiola SM. North Carolina family practice physicians'

perceptions of pharmacists as vaccinators. J Am Pharm Assoc. 2005;45:486-491.

Blalock SJ, Patel RA. The Drug Therapy Concerns Scale: Initial development and

refinement. J Am Pharm Assoc. 2005;45:160-169.

McIntosh J, Blalock SJ. Effects of media coverage of the Women’s Health Initiative on the

attitudes and behavior of women regarding hormone replacement therapy. Am J Health

Syst Pharm. 2005;62:69-74.

BLALOCK

6

Patel R, Carr-Lopez SM, Blalock SJ. Assessment of clinical endpoints and medication

utilization in patients with type 2 Diabetes. J Air Force Pharm. 2004;11(2): 93-98.

Blalock SJ, Norton LL, Patel RA, Cabral K, Thomas CL. Development and assessment of a

short instrument for assessing dietary intakes of calcium and vitamin D. J Am Pharm

Assoc. 2003;43:685-693.

Blalock SJ, DeVellis BM, Patterson CC, Campbell MK, Orenstein DR, Dooley MA. Effects

of an osteoporosis prevention program incorporating tailored educational materials. Am

J Health Promot. 2002;16:146-156.

Knapp KK, Blalock SJ, Black B. ASHP survey of ambulatory care responsibilities of

pharmacists in integrated health systems, 2001. Am J Health Syst Pharm. 2001;58:

2151-2166.

Ainsworth BE, Anderson LA, Becker DM, Blalock SJ, Brown DR, Brownson RC,

Brownstein N, Cornell CE, DeVellis BM, Finnegan LP, Folger S, Fulton JE, Groff JY,

Herman C, Jones D, Keyserling TC, Koffman DM, Lewis C, Masse LE, McKeown RE,

Orenstein D, Spadaro AJ. Community prevention study: Contributions to women’s

health and prevention research. J Womens Health Gend Based Med 2001;10(10):913-

920

Blalock SJ, Currey SS, DeVellis RF, DeVellis BM, Giorgino KB, Anderson JJB, Dooley

MA, Gold DT. Effects of educational materials concerning osteoporosis on women’s

knowledge, beliefs, and behavior. Am J Health Promot. 2000;14:161-169.

Ferrill MJ, Blalock SJ, Norton LL. A survey of the literature evaluation skills of health-

system pharmacists. Hosp Pharm. 2000;35:721-727.

Ferrill MJ, Norton LL, Blalock SJ. Determining the statistical knowledge of pharmacy

practitioners: A survey and review of the literature. Am J Pharm Educ. 1999;63:371-

376.

Blanchard LW, Blalock SJ, DeVellis RF, DeVellis BM, Johnson MR. Social comparison

among mothers of premature and full-term infants. Child Health Care. 1999;28:329-

348.

Knapp KK, Blalock SJ, O’Malley CH. ASHP survey of ambulatory care responsibilities of

pharmacists in integrated health systems, 1999. Am J Health Syst Pharm.

1999;56:2431-2443.

Blalock SJ, Orlando M, Mutran EJ, DeVellis RF, DeVellis BM. Effect of satisfaction with

one’s abilities on positive and negative affect among individuals with recently

diagnosed rheumatoid arthritis. Arthritis Care Res. 1998;11:158-165.

Blalock SJ, DeVellis RF. Health salience: Reclaiming a concept from the lost and found.

Health Educ Res. 1998;13:399-406.

Blalock SJ, Currey SS, DeVellis RF, Anderson JJB, Gold DT, Dooley MA. Using a short

food frequency questionnaire to estimate dietary calcium consumption: A tool for

patient education. Arthritis Care Res. 1998;11:479-484.

DeVellis RF, Carl KL, DeVellis BM, Blalock SJ, Patterson CC. Correlates of changes in

mood following a mood induction in osteoarthritis patients. Arthritis Care Res.

1998;11:234-242.

DeVellis RF, Patterson CC, Blalock SJ, Renner BR, DeVellis BM. Do people with

rheumatoid arthritis develop illness-related schemas? Arthritis Care Res. 1997;10:78-

88.

BLALOCK

7

Callahan LF, Blalock SJ. Behavioral and social research in rheumatology. Curr Opin

Rheumatol. 1997;9:126-32.

Blalock SJ, DeVellis RF, Giorgino KB, DeVellis BM, Gold DT, Dooley MA, Anderson JJB,

Smith SL. Osteoporosis prevention in premenopausal women: Using a stage model

approach to examine the predictors of behavior. Health Psychol. 1996;15:84-93.

Freeman JB, Blalock SJ, Holman HR, Liang MH, Meenan RF. Advances brought by

healthservices research to patients with arthritis: Summary of the workshop Health

Services Research in Arthritis: From research to practice. Arthritis Care Res.

1996;9:142-150.

Blalock SJ, DeVellis BM, Giorgino KB. The relationship between coping and

psychologicalwell-being among people with osteoarthritis: A problem-specific

approach. Ann Behav Med. 1995;17:107-115.

Zautra AJ, Burleson MH, Smith CA, Blalock SJ, Wallston KA, DeVellis RF, DeVellis BM,

Smith TW. Arthritis and the quality of life experience: An examination of positive and

negative affect in rheumatoid arthritis patients. Health Psychol. 1995;14:399-408.

Giorgino KB, Blalock SJ, DeVellis RF, DeVellis BM, Keefe FJ, Jordan JM. Appraisal of

and coping with arthritis-related problems in three areas: Household activities, leisure

activities, and pain management. Arthritis Care Res. 1994;7:20-28.

Upchurch G, Earp JA, Blalock SJ. Access to medications for low income North Carolina

citizens: Without funds, how can they follow doctor's orders? N C Med J. 1994;55:173-

177.

Blalock SJ, Bunker BJ, DeVellis RF. Measuring health status among survivors of burn

injury: Revision of the Burn Specific Health Scale. J Trauma. 1994;6:508-515.

Blalock SJ, Bunker BJ, DeVellis RF. Psychological distress among survivors of burn injury:

The role of outcome expectations and perceptions of importance. J Burn Care Rehabil.

1994;15:421-427.

Blalock SJ, DeVellis BM, Holt K, Hahn PM. Coping with rheumatoid arthritis: Is one

problem the same as another? Health Educ Q. 1993;20:119-132.

DeVellis BM, Blalock SJ. Illness attributions and hopelessness depression: The role of

hopelessness expectancy. J Abnorm Psychol. 1992;101:257-264.

Blalock SJ, Bunker BJ, Moore JD, Foreman N, Walsh JF. The impact of burn injury: A

preliminary investigation. J Burn Care Rehabil. 1992;13:487-492.

Blalock SJ, DeVellis BM, DeVellis RF, Giorgino KB, Sauter SVH, Jordan JM, Keefe FJ,

Mutran EJ. Psychological well-being among people with recently-diagnosed

rheumatoid arthritis: Do self-perceptions of abilities make a difference? Arthritis

Rheum. 1992;35:1267-1272.

DeVellis RF, Blalock SJ, Holt K, Renner BR, Blanchard LW, Klotz ML. Arthritis patients'

reactions to unavoidable social comparisons. Pers Soc Psychol Bull. 1991;17:392-399.

DeVellis RF, Holt K, Renner BR, Blalock SJ, Blanchard LW, Cook HL, Klotz ML, Mikow

V, Harring K. The relationship of social comparison to rheumatoid arthritis symptoms

and affect. Basic Appl Social Psych. 1990;11:1-18.

DeVellis BM, Blalock SJ, Sandler RS. Predicting participation in cancer screening: Testing

the theory of planned behavior. J Appl Soc Psychol. 1990;20:639-660.

Blalock SJ, Afifi RA, DeVellis BM, Holt K, DeVellis RF. Adjustment to rheumatoid

arthritis: The role of social comparison processes. Health Educ Res. 1990;5:361-370.

BLALOCK

8

Blalock SJ, DeVellis BM, Afifi RA, Sandler RS. Risk perceptions and participation in

colorectal cancer screening. Health Psychol. 1990;9:792-806.

Blalock SJ, Sauter SVH, DeVellis RF. The Modified Health Assessment Questionnaire

Difficulty Scale: A health status measure revisited. Arthritis Care Res. 1990;3:182-188.

Blalock SJ, DeVellis BM, DeVellis RF. Social comparison among individuals with

rheumatoid arthritis. J Appl Soc Psychol. 1989;19:665-680.

Sandler RS, DeVellis BM, Blalock SJ, Holland KL. Participation of high risk subjects in

colon cancer screening. Cancer. 1989;63:2211-2215.

Blalock SJ, DeVellis RF, Brown GK, Wallston KA. Validity of the Center for

Epidemiological Studies Depression Scale in arthritis populations. Arthritis Rheum.

1989;32:991-997.

DeVellis BM, Blalock SJ, Hahn PM, DeVellis RF, Hochbaum GM. Evaluation of a

problem-solving intervention for patients with arthritis. Patient Educ Couns.

1988;11:29-42.

Blalock SJ, DeVellis BM, DeVellis RF, Sauter S. Self-evaluation processes and adjustment

to rheumatoid arthritis. Arthritis Rheum. 1988;31:1245-1251.

Blalock SJ, DeVellis BM, Sandler RS. Participation in fecal occult blood screening for

colorectal cancer: A critical review. Prev Med. 1987;16:9-18.

Blalock SJ, DeVellis BM. Stereotyping: The link between theory and practice. Patient Educ

Couns. 1986;8:17-25

Refereed Presentations with Published Abstracts

Elstad E, Carpenter D, DeVellis R, Blalock S. The impact of conflicting medication

information on patients’ trust in information sources. Ann Behav Med 2011;41:S30.

Cohen MG, Sleath BL, Blalock S, Cerna AR, Bender DE. Latino’s attitudes and preferences regarding treatment of hypertension. Circulation. 2008;118(12):E297-298.

Thorpe CT, DeVellis RF, Lewis MA, Hogan SL, Blalock SJ, DeVellis BM. Development and initial evaluation of a measure of self-management for adults living with ANCA-associated small vessel vasculitis. Arthritis Rheum. 2007;25(1):S115-S116.

Kelly KB, Ball AM, Miller AD, Haslam WD, Mangum L, Malone R, Bryant B, Jones M,

Scott M, Cox W, Parker MH, Murray M, Blalock S, Adams P, Sueta C, Rodgers JE. Impact of medication access on adherence and outcomes of outpatients with heart failure. Pharmacotherapy. 2005;25(3):470.

Blalock SJ, Norton LL, Patel RA. Adherence to the American College of Rheumatology Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum. 2004;50:S682.

Welch A, Ferreri S, Caiola S, Blalock S. Physicians perceptions of pharmacists as vaccinators. J Am Pharm Assoc. 2004;44(2):266.

Blalock SJ, Norton LL, Patel RA. Osteoporosis prevention among people with rheumatoid arthritis receiving oral glucocorticoid therapy. J Am Pharm Assoc. 2003;43(2):311-312.

Blalock SJ, Patel RA. The Drug Therapy Concerns Scale: Findings from the initial scale development phase. J Am Pharm Assoc. 2003;43(2):316.

Blalock SJ. Women’s knowledge and beliefs concerning estrogen and osteoporosis risk-

reduction. J Am Pharm Assoc. 2001;41(2):312.

BLALOCK

9

Blalock SJ, Patterson CC, Dooley MA, DeVellis RF, Orenstein D. Women’s knowledge and

beliefs concerning estrogen and osteoporosis risk-reduction. Arthritis Care Res. 1998;

11:S8.

Blalock SJ, Currey SS, DeVellis RF, DeVellis BM, Dooley MA. Effects of educational

materials concerning osteoporosis on women’s knowledge, beliefs, and behavior.

Arthritis Care Res. 1998;11:S7.

Blalock SJ, Smith SL: Osteoporosis prevention. Longitudinal predictors of behavior change.

Arthritis Rheum. 1997;40(9):S319.

Dooley MA, Giorgino KB, Blalock SJ, DeVellis RF, Estrada A, Rice JR. Validation of a

self-administered screening instrument for fibromyalgia. Arthritis Rheum.

1997;40(9):S129.

Smith SL, Blalock SJ. Predictors of reading educational materials about osteoporosis

prevention. Arthritis Rheum.1996;39(9):S125.

Giorgino KB, DeVellis RF, Blalock SJ, Rice JR, Dooley MA. Assessing the feasibility of a

self-administered screening instrument for fibromyalgia. Arthritis Rheum. 1996;

39(9):S322.

Blalock SJ, DeVellis RF. Development of a measure to assess general health motivation.

Arthritis Rheum. 1995;38:S319.

Blalock SJ, DeVellis RF, Giorgino KB, DeVellis BM, Gold DT, Dooley MA, Anderson

JJB,Smith SL. Osteoporosis prevention: Using a stage model approach to examine the

predictors of exercise activity and calcium consumption. Arthritis Rheum.

1995;38:S311.

Blalock SJ, DeVellis RF, DeVellis BM, Giorgino KB, Mutran EJ. The relationship

betweendepression and physical functioning in rheumatoid arthritis. Arthritis Care Res.

1992;5:S8.

Fifield J, Reisine S, Blalock SJ, DeVellis RF, Allaire SH. Psychosocial theories in arthritis

research: A multidisciplinary approach. Arthritis Care Res. 1991;4:S16.

Blalock SJ, DeVellis BM, DeVellis RF, Giorgino KB, Sauter S, Keefe FJ. An examination

of self-evaluation processes among individuals with recently-diagnosed rheumatoid

arthritis. Arthritis Care Res. 1991;4:S21.

Giorgino KB, Blalock SJ, DeVellis BM, DeVellis RF. The nature of social and

temporalcomparisons made by individuals with recently diagnosed rheumatoid arthritis.

Arthritis Care Res. 1991;4:S14.

Patterson CC, Healy JC, DeVellis RF, Blalock SJ. What RA patients think about, that

theirdoctors may not know. Arthritis Care Res. 1991;4:S14.

Giorgino KB, Blalock SJ, DeVellis BM, Jordan J, DeVellis RF. Methods to minimize

attrition in longitudinal studies. Arthritis Care Res. 1991;4:S28.

Blalock SJ, Sauter SVH, DeVellis RF. Assessment of functional capacity and actual function

using self-report measures. Arthritis Care Res. 1989;2:S22.

Sauter SVH, Blalock SJ, DeVellis RF. Assessment of function in OA by significant others.


Blalock SJ, DeVellis RF. Validity of the Center for Epidemiological Studies Depression

Scale in arthritis populations. Arthritis Rheum. 1988;31:S156.

BLALOCK

10

DeVellis RF, Blalock SJ, Holt K, Renner BR, Blanchard LW, Cook HL. Effects of

socialcomparisons provided to rheumatoid arthritis patients. Arthritis Rheum. 1988;31:

S157.

Sandler RS, DeVellis BM, Blalock SJ, Holland KL. Participation of high-risk subjects in

colon cancer screening. Gastroenterology. 1988;94(5):A398.

Blalock SJ, DeVellis BM, DeVellis RF. Role of social comparison in self-evaluation of

ability. Arthritis Rheum. 1987;30:S198.

DeVellis RF, Blalock SJ. Development and validation of psychosocial measures in

arthritis.Arthritis Rheum. 1986;29:S145.

Blalock SJ, DeVellis BM, Hahn PM. Predictors of adjustment to rheumatoid arthritis.


Other Presentations

Blalock SJ, Chewning B, Raynor DKT, Sleath BL. Improving communication of medication

harms and benefits to patients: Research-based developments from the UK and USA.

Symposium to be presented at the International Conference on Communication in

Healthcare, St. Andrews, Scotland, September 2012.

Blalock SJ, Sleath BL, Hunter J, Revollo J, Chandiramani D. Communicating risks

associated with prescription medications. Paper presented at the International

Conference on Communication in Healthcare, Chicago, IL, October 2011.

Leone AL, Ives TJ, Blalock SJ. Pharmacotherapeutic treatment of anxiety disorders:

investigating the correlation between GAD-7, PHQ-9, and Brief Pain Inventory scores.

Paper presented at the American College of Clinical Pharmacy Spring Practice

and Research Forum, Charlotte, NC, April 2010

Cohen MG, Sleath BL, Blalock SJ, Cerna AR. Latino’s attitudes and preferences regarding treatment of hypertension. Paper presented at the World Congress of Cardiology, Buenos Aires, Argentina, May 2008.

Blalock SJ. Preventing falls through enhanced pharmaceutical care. Paper presented at the

National Injury and Violence Prevention Research Conference. Society for the

Advancement of Injury and Violence Research, September 2007, Columbus, OH, GA.

Blalock SJ. Preventing falls through enhanced pharmaceutical care. Paper presented at the

Unintentional Injury/Falls Related Research Grantee Meeting, sponsored by the Centers

for Disease Control and Prevention, May 7-8, 2007, Atlanta, GA.

Blalock SJ. Patient perceptions of using hip protectors to reduce fracture risk. Paper

presented at the Unintentional Injury/Falls Related Research Grantee Meeting,

sponsored by the Centers for Disease Control and Prevention, May 7-8, 2007, Atlanta,

GA.

Blalock SJ, Brock T, Sleath B. Bringing theory to life. Workshop conducted at the 14th

International Social Pharmacy Conference, St. Anne’s College, Oxford, July 2006.

Ferrill MJ, Brown DL, Blalock SJ. The determinants of teaching effectiveness: A survey of

2004 teachers of the year. American Association of Colleges of Pharmacy Annual

Meeting, Cincinnati, July 2005.

BLALOCK

11

Blalock SJ, Patel RA. Development of an instrument to assess subjective drug therapy

concerns. Poster presentation at the130th

Annual Meeting and Exposition of the

American Public Health Association, Philadelphia, November 2002.

Blalock SJ. Structural equation modeling with latent variables: Issues and applications.

Podium presentation at the Annual Meeting of the American College of Clinical

Pharmacy, Los Angeles, November 2000.

Blalock SJ, Bunker BJ, DeVellis, RF. Measurement of health status among survivors of

burn injuries. Podium presentation at the 120th

Annual Meeting and Exposition of the

American Public Health Association, Atlanta, November 1992.

Blalock SJ, Bunker BJ, Moore JD, Foreman N. Rehabilitation from burn injury. Podium

presentation at the 119th

Annual Meeting and Exposition of the American Public Health

Association, Atlanta, November 1991.

Blalock SJ, DeVellis BM, Holt K, Hahn PM. Assessment of coping among individuals with

rheumatoid arthritis. Podium presentation at the 119th

Annual Meeting and Exposition

of the American Public Health Association, Atlanta, November 1991.

Blalock SJ, Sauter SVH, DeVellis RF. Conceptual issues in the measurement of health

status: An empirical investigation. Podium presentation at the 10th

Annual Meeting of

the Society of Behavioral Medicine, San Francisco, April 1989.

DeVellis BM, Blalock SJ. Coping processes and adjustment to rheumatoid arthritis. In: TA

Revenson and KA Wallston (Symposium Chairs), Adaptation to chronic illness:

Rheumatoid arthritis as exemplar. Podium presentation at the 97th

Annual Convention

of the American Psychological Association, New Orleans, August 1989.

DeVellis BM, Blalock SJ, Holland KL, Sandler RS. Determinants of colorectal cancer

screening among those at high risk. Podium presentation at the 9th

Annual Meeting of

the Society of Behavioral Medicine, Boston, April 1988.

Sandler RS, DeVellis BM, Blalock SJ, Holland KL. High risk subjects in colon cancer

screening. Podium presentation at the Annual Meeting of the American

Gastroenterological Association, New Orleans, May 1988.

Blalock SJ, DeVellis BM, DeVellis RF. Social comparisons among individuals with


Annual Meeting of the Society of

Behavioral Medicine, Washington DC, March 1987.

Blalock SJ, DeVellis BM, DeVellis RF. Social comparison processes and adjustment to


Annual Convention of the

American Psychological Association, New York City, August 1987.

Blalock SJ. Adjustment to illness through social comparison. In: BM DeVellis (Symposium

Chair), Applying psychosocial theory to practice: Promises and pitfalls. Podium

presentation at the Society of Public Health Education Midyear Scientific Meeting,

Chapel Hill, North Carolina, June 1986.

DeVellis BM, Blalock SJ, Hahn PM. Theory based interventions in rheumatoid arthritis.

Podium presentation at the 93rd

Annual Convention of the American Psychological

Association, Los Angeles, August 1985.

Hahn PM, Blalock SJ, DeVellis BM. Use of a problem solving intervention with patients

with rheumatoid arthritis. Podium presentation at the 113th

Annual Meeting and

Exposition of the American Public Health Association, Washington DC, November

1985.

BLALOCK

12

BLALOCK

13

TEACHING RECORD

Classroom Teaching: Classes that include coordination responsibilities

Course Role Semesters

Drug Literature Analysis and Interpretation

(Pharm 433)

School of Pharmacy


Course Coordinator

Instructor

Fall 2003-10

Fall 2002

Social & Behavioral Aspects of Pharmaceutical Use

(DPOP 803)

School of Pharmacy


Co-Course

Coordinator

Spring 2005

Spring 2007

Spring 2009

Spring 2011

Patient-Reported Outcomes: Theory, Methods, and

Applications

(DPOP 805)

School of Pharmacy


Co-Course

Coordinator

Spring 2004

Spring 2006

Applied Pharmaceutical Statistics

(Pharm 192)

School of Pharmacy


Instructor Fall 2002

Statistics and Experimental Design

(PCSP 201)

TJ Long School of Pharmacy

University of the Pacific

Co-Course

Coordinator

Summer 2002

Pharmacy Systems and Experiences V

(Phar 151)



Course Coordinator Spring 2000-

02

Pharmaceutical Calculations and Statistics

(Phar 112)



Course Coordinator Fall 1999-

2001

BLALOCK

14

Course Role Semesters

Contemporary Pharmacy Practice

(Phar 162)



Course Coordinator Spring 1999

Doctoral Seminar: Professional issues

(HBHE 312)



Co-Course

Coordinator

Fall 1998

Fall 1996

Social and Behavioral Science Foundations of

Health Education

(HBHE 130)



Course Coordinator

Guest Lecturer

Fall 1993

Fall 1984-98

Fall 2009-10

Classroom Teaching: Guest Lectures

Course Semesters

Injury and Violence (EPID 783)

2006, 07, 09, 11

Dietary Change Interventions (NUTR 715) 2009

Special Topics in Health Policy and Administration: Proposal

writing (HPAA 872) 2006-2009

Ethics in Research (PHCY 801) 2007-08

Pharmaceutical Care Lab V (PHCY 405) 2007-08

Aging and Health (EPID 604) Fall 2005-07

BLALOCK

15

Dissertation Committees

Student: Dissertation Title Department1 Committee

Role Year

Christopher Gillette: The Effect of Risk, Side Effect, and Benefit Communication on Asthma Control

Medication Adherence in Pediatric Patients

DPOP Member Current

Walter Palmer: Evaluation of the Matter of Balance Program

HMSC Member Current

Deidre Washington: The Effect of Patient’s Race on Patient-Provider Communication with Pediatric Asthma

Patients

DPOP Chair 2010

Hisham Aljadhey: The effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on blood pressure, renal

function, and serum potassium concentrations.

DPOP Member 2008

Ashley Beard: Cost as a feature of medication management communication in medical visits.

DPOP Member 2008

John Byrd: Impact of medication stressors on emotional health of informal caregivers of demented

patients.

DPOP Member 2007

Suzanne Cadarette: Barriers to and facilitators of osteoporosis investigation and treatment among older

community-dwelling women in Ontario: Application of

a health services utilization conceptual framework.

University

of Toronto

External

Reviewer

2006

Mark Patterson: Effect of prescription copayments on medication persistence and hospitalizations in

commercially insured patients with heart failure.

DPOP Member 2006

Carolyn Thorpe: Treatment adherence among adults living with ANCA small vessel vasculitis.

HBHE Member 2006

Joshua Thorpe: Health care utilization in community-dwelling persons with dementia: The role of informal

caregiver emotional health.

DPOP Member 2005

Suzanne Folger: Exploring risk factors for respiratory illnesses: Are children who live near waste

incinerators at increased risk?

EPID Member 1996

Kathryn Luchok: Social support and women's health during pregnancy and postpartum among the Yoruba of

Nigeria.

HBHE Member 1993

1 HBHE: Department of Health Behavior and Health Education, UNC School of Public Health; DPOP: Division

of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy; EPID: Department of

Epidemiology, UNC School of Public Health; HMSC: Human Movement Science, Department of Allied Health

Science, UNC School of Medicine.

http://proquest.umi.com.libproxy.lib.unc.edu/pqdweb?index=0&did=1629574721&SrchMode=2&sid=9&Fmt=2&VInst=PROD&VType=PQD&RQT=309&VName=PQD&TS=1235886633&clientId=15094http://proquest.umi.com.libproxy.lib.unc.edu/pqdweb?index=0&did=1629574721&SrchMode=2&sid=9&Fmt=2&VInst=PROD&VType=PQD&RQT=309&VName=PQD&TS=1235886633&clientId=15094

BLALOCK

16

Masters Committees

Student: Project Title Department1 Committee

Role Year

Kim Faurot: The role of the community pharmacist in dietary supplement education: An

exploratory study.

HBHE Reader 2005

Kara Suter: The effect of health literacy on outcomes.

DPOP Chair 2003

Angela DeVeaugh-Geiss: Factors influencing family physician counseling about folic acid and

neural tube defects.

DPOP Reader 2003

Gina Upchurch: Access to medications for North Carolina's indigent population: A policy

analysis.

HBHE Reader 1993

Jerrel Moore: Attributions, learned helplessness, and problem solving in rheumatoid arthritis

patients.

HBHE Reader 1988

1 HBHE: Health Behavior and Health Education, UNC School of Public Health; DPOP: Pharmaceutical

Outcomes and Policy, UNC Eshelman School of Pharmacy.

Academic Advisor: PhD

Anne Beaubrun, 2008-2011

Deidre Washington, 2005-2010

Stacie Dusetzina, 2006-2008

Melissa Butler: 2003-2008

Mark Patterson: 2002-2003

Academic Advisor: PharmD

PharmD Classes of 2008, 2013, 2014: Approximately 12 advisees/class

Pharmacy Residents

Teresa Anderson, PharmD, 2006-07

Stephen Stricker, PharmD, 2006-07

Amanda Whitehead, PharmD, 2005-06

Ashley McNeill, PharmD, 2005-06

Amanda Lehenbauer, PharmD, 2005-06

Adam Welch, PharmD, 2004-05

Jennifer McIntosh, PharmD, 2002-03

Independent Study

Helen Smith, Spring 2008

Renee Howard, Academic Year 2006-07

Annie Yi, Spring 2007

Leslie Pritchard, Fall 2004

Amar Vyas: Academic Year 2004-05

BLALOCK

17

GRANTS AND CONTRACTS

PRINCIPAL INVESTIGATOR (PRIME)

Project Information Approx. Total

Direct Costs

Communicating Risks Associated with Prescription Medications

American College of Rheumatology Research and Education Foundation

2010-2012

$367,000

Medication Therapy Management: Older adult and pharmacist

perceptions

University Research Council

2006-08

$4,500

Osteoporosis Prevention among People with Rheumatoid Arthritis

Receiving Oral Glucocorticoid Therapy

Arthritis Foundation

July 2000-June 2005

$400,000

Health Outcomes and Patient Education Project: The Carolina

Community Pharmacy Patient Panel

UNC-CH School of Pharmacy Faculty Seed Grant

May 2004-April 2005

$8,400

Development of the Pharmaceutical Care Concerns Scale

Scholarly and Artistic Activity Grant, University of the Pacific

September 1999-August 2000

$1,885

Coping with Osteoarthritis: An examination of strategies used to deal

with four illness-related problems

Arthritis Foundation

1991-94

$75,000

Self-Care Education for Medication Use Manual

North Carolina Department of Environment, Health and Natural

Resources

1990-91

$4,250

Self-Evaluation of Functional Abilities Among Patients with

Rheumatoid Arthritis

Arthritis Health Professions Traineeship

1985-87

$32,000

BLALOCK

18

PRINCIPAL INVESTIGATOR ON PROJECTS WITHIN CENTER GRANTS


Direct Costs

Translational Research to Identify Factors Related to Older Adult Use

of Evidence-Based Falls Prevention Programs

Project within UNC Injury Prevention Research Center (IPRC)

Centers for Disease Control and Prevention

IPRC Principal Investigator: Carol W. Runyan, PhD

Interim IPRC Director: Stephen Marshall, PhD

June 2011-July 2013

$200,000

Preventing Falls Through Enhanced Pharmaceutical Care




August 2004-July 2009

$730,000

Patient Perceptions of Using Hip Protectors to Reduce Fracture Risk




August 2004-July 2005

$69,000

Osteoporosis Prevention: Education and outreach

Project within UNC Health Promotion and Disease Prevention Center

(HPDP)


HPDP Principal Investigator: Carl Cross, MD

October 1995-September 1998

$580,000

Osteoporosis Prevention: Application and testing of the Precaution

Adoption Process

Project within UNC Multipurpose Arthritis Research Center

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Center Principal Investigator: John B. Winfield, MD

1993-96

$308,000

Genetic Testing for Breast Cancer Susceptibility: An exploratory study

of educational issues

Project within UNC Breast Cancer Specialized Programs of Research

Excellence (SPORE)

National Cancer Institute

SPORE Principal Investigator: Edison Liu, MD

1994-96

$27,000

Adjustment to Rheumatoid Arthritis: The role of the self-evaluation

processes

$300,000

BLALOCK

19




1988-92

Determinants of Burn Rehabilitation

Project within UNC Injury Prevention Research Center

(IPRC)



1990-92

$90,000

DIRECTOR OF CORES WITHIN CENTER GRANTS


Direct Costs

Numerical Sciences Core

Core within UNC Multipurpose Arthritis Research Center



1993-98

$555,000

PRINCIPAL INVESTIGATOR ON SUBCONTRACTS


Direct Costs

Consumer Assessment of Pharmacist/Pharmacy Services

American Institutes for Research (Prime: Pharmacy Quality Alliance)

2007

$22,000

SENIOR INVESTIGATOR (MENTOR)


Direct Costs

Anti-osteoporosis Medication Trends and Determination in the US

Ambulatory Population from 1996-2004: Results from the Medical

Expenditure Panel Survey (MEPS)

Principal Investigator: Joel Farley, PhD

American Society of Health-System Pharmacists

2006-08

$17,000

BLALOCK

20

CO- INVESTIGATOR


Direct Costs

Communication About Glaucoma and Patients Outcomes

Principal Investigator: Betsy Sleath, PhD

National Eye Institute

2009-13

$1,790,000

Closing the quality gap series: revisiting the state of the science quality

improvement interventions and/or programs to improve prescription

medication adherence

Principal Investigator: Carol Golin, MD

Research Triangle Institute (Prime: AHRQ)

2010-11

$108,000

Determining the Effects of Conflicting Medication Information and

Spouse Support on the Medication Adherence of Osteoarthritis Patients

Principal Investigator: Delesha Miller, PhD

Novartis

2010

$85,000

The Effect of Medicaid Prescription Restrictions on Mental Health

Utilization

Principal Investigator: Joel Farley, PhD

Pfizer, Inc.

2007-09

$130,000

Enhancing Pneumococcal Vaccination Rates through Community

Pharmacist Involvement

Principal Investigator: Stefanie Ferreri, PharmD


October 2005-September 2007

$185,000

Wisewoman Medication Empowerment Module

Principal Investigator: Thomas Keyserling, MD


2006

$12,000

The Impact of Traumatic Spinal Cord Injury: Development of a system

to assess long-term health outcomes and patterns of health service

utilization

Principal Investigator: Michael Y. Lee, MD


1994-96

$108,000

BLALOCK

21

Selective Remembering of Information by Arthritis Patients


Project Principal Investigator: Robert F. DeVellis, PhD



1988-93

$335,000

Validity of Self-Report Measures of Functional Ability and Actual

Function

Principal Investigator: Suzanne Sauter, MD

University of North Carolina Medical Faculty Grant

1988-89

$3,000

Self-Evaluation of Physical Abilities

Principal Investigator: Brenda M. DeVellis, PhD

University of North Carolina Research Council Grant

1985-87

$1,500

PROFESSIONAL SERVICE

SERVICE AT NATIONAL/INTERNATIONAL LEVEL

Invited Presentations

Communicating risks associated with prescription medications. American

College of Rheumatology Foundation: Within Our Reach Investigators

Meeting, Santa Fe, NM

January

2012

Communicating risks associated with prescription medications. American

College of Rheumatology Foundation: Within Our Reach Investigators

Meeting, Miami, FL.

June 2011

Comparative effectiveness research in community pharmacy settings.

Chapel Hill Drug Conference, Chapel Hill, NC.

May 2011

Communicating risks associated with prescription medications: A fuzzy

trace approach. Worldwide Universities Working Conference, Sydney,

Australia.

May 2010

The Theoretical Basis for Practice-Relevant Medication Use Research.

Presented at the Conference on Enhancing the Rigor and Utility of

Medication Use Research. Co-sponsored by the American Association of

Colleges of Pharmacy, the International Society of Pharmacoeconomics and

Outcomes Research, the Pharmacy Practice Research Alliance, and the US

Pharmacopeia.

January

2009

BLALOCK

22

Physician-Patient Communication: The case of osteoporosis.

Congressional Briefing, Rayburn Building, Washington DC. Hosted by the

Alliance on Aging.

May 2005

Calcium compliance: Insights from past research. Calcium for Life

Roundtable Meeting, New York City. Hosted by Innovative Science

Solutions, SENSEI Health, and GSK.

June 2004

Osteoporosis prevention among people with rheumatoid arthritis receiving

oral glucocorticoid therapy: Research in progress. Podium presentation at

the Arthritis Foundation Grant Forum conducted in conjunction with the

Annual Scientific Meeting of the Association of Rheumatology Health

Professionals, San Francisco.

November

2001

Osteoporosis prevention: Strong Bones for Life Project. Presentation for

the 50+ and Strong Alliance, Walnut Creek, CA.

January

2001

Addressing the effectiveness of community outreach interventions for

women in improving osteoporosis prevention behaviors. Podium

presentation at the Community Prevention Research in Women’s Health

Conference, Sponsored by the National Institutes of Health, Washington DC.

October

2000

In Search of Clinical Relevance Workshop. (Speaker) Presented at the

Annual Scientific Meeting of the Association of Rheumatology Health

Professionals, Boston.

November

1999

Workshop for Health Services Research in Arthritis: From research to

practice. (Co-Chair) Sponsored by The National Advisory Board for Arthritis

and Musculoskeletal and Skin Diseases and The National Institute of Arthritis

and Musculoskeletal and Skin Diseases. Bethesda, MD.

April 1994

Psychosocial models underlying patient coping. Podium presentation at the

Workshop for Health Services Research in Arthritis: From research to

practice. Sponsored by The National Advisory Board for Arthritis and

Musculoskeletal and Skin Diseases and The National Institute of Arthritis

and Musculoskeletal and Skin Diseases, Bethesda, MD.

April 1994

Committee Memberships

American Pharmacists Association Social and Administrative Sciences

Graduate Program Committee

2010-11

Ad hoc Committee on Patient-Based Research, American College of

Rheumatology

1999-2000

Research Committee, Association of Rheumatology Health Professionals 1998-2000

Program Planning Committee, Association of Rheumatology Health

Professionals

1990-91

BLALOCK

23

Editorial Boards and Service

Current Rheumatology Reviews 2004-

Present

Arthritis Care and Research 1995-2001

Arthritis Care and Research, Guest Editor, Special issue on patient and

public health education

1998

Arthritis Care and Research, Guest Editor, Special issue on health status

assessment

1992

Manuscript Review for Professional Journals (Since 2007)

Arthritis and Rheumatism

2007-

Present

Journal of the American Pharmacists' Association

2007-

Present

Osteoporosis International

2008-

Present

BMC Public Health 2010

Annals of Behavioral Medicine 2010

Annals of Internal Medicine 2010

International Journal of Injury Control and Safety 2010

Journal of Behavioral Medicine

2008-09

American Journal of Preventive Medicine 2007 & 09

American Journal of Public Health 2008

Journal of the American Geriatrics Society 2007

Journal of Womens Health 2007

American Journal of Managed Care Pharmacy 2007

Abstract Review for Annual Meetings

American Pharmacists' Association Annual Meeting 2004-

Present

International Society for Pharmacoeconomics and Outcomes Research.

Quality of Life Panel

2002-03

BLALOCK

24

Association of Rheumatology Health Professionals. Research Methods

Panel

2000

Grant Review

Agency for Healthcare Research and Quality. Clinical and Health

Outcomes Initiative in Comparative Effectiveness (CHOICE) Grants

(R01) (Member of scientific review panel)

2010

American College of Rheumatology. REF Study Section (Chaired study

section in 2007 and 2008)

2006-

2008

Arthritis Foundation. Clinical Sciences Section (Ad hoc reviewer) 2004

Association of Rheumatology Health Professionals: Pre-review panel for

Arthritis Foundation grant proposals

2002

Arthritis Foundation. Clinical Sciences Study Section 1994-

97

National Institute of Arthritis and Musculoskeletal and Skin Diseases,

NIAMS Centers Working Group 1. Ad hoc advisory group assembled to

provide advice concerning the Research Centers funding mechanism

1996


(NIAMS). Member of site visit team, University of California - Los

Angeles

1992

SERVICE TO THE STATE OF NORTH CAROLINA (2002-PRESENT)

North Carolina Falls Prevention Coalition, Chair of Community

Awareness and Education Working Group

2008-10

Scientific review of materials created as part of Project Lazarus in

Wilkes County (Materials designed to reduce mortality from opiod

overdose)

2009

Communicating information concerning medication risks. Continuing

education session presented at the Northwest Area Health Education

Center, Winston Salem

November,

2009

Member of Medication Therapy Management Taskforce of North

Carolina Association of Pharmacists

2007

Carolina Center for Public Service, Member of Peck Elementary Grant

Writing Seminar Team 2004-05

BLALOCK

25

SERVICE TO THE STATE OF CALIFORNIA (1998-2002)

California Breast Cancer Research Council 1999-2002

California Breast Cancer Research Council, Evaluation and Priority

Setting Subcommittee (Chair)

2001-02

SERVICE TO UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

Injury Prevention Research Center

Member of Core Faculty Group 2004-Present

Chair of Faculty Small Grants Review Committee 2009-10

Member of Biostatistical Core Review Working Group 2009-10

Reviewer for Susan P. Baker Student Research Paper Prize 2004-10

Chair of Dissemination Research Solicitation Committee 2005-06

Health Promotion and Disease Prevention Center

Member of Scientific Advisory Committee 2004-Present

Other

Review Committee for Dean John Williams, School of Dentistry 2009

Review Committee for Carol Runyan, Director of the UNC Injury

Prevention Research Center 2009

UNC Tomorrow Campus Response Committee (Health) 2008

BLALOCK

26

SERVICE TO UNC ESHELMAN SCHOOL OF PHARMACY

School of Pharmacy Standing Committees

Graduate Education Committee: Divisional Director of Graduate

Studies

2006-09

2011-Present

Community Pharmacy Advisory Committee 2007-09

Assessment Committee 2005

Admissions Committee 2003-06

2009-10

Honors Committee 2002-06

2009-11

Scholarship Committee 2002-06

School of Pharmacy Ad Hoc Committees

ACPE Self-Study Steering Committee: Chair of Mission, Planning

and Evaluation Subcommittee 2010-12

Planning Committee: Asheville Satellite Program 2010-11

Planning Committee: Rural Pharmacy Health Initiative 2010-11

Search Committee: DPOP Faculty 2006-07

2010-11

Search Committee: Associate Dean for Research and Graduate

Education 2007

Search Committee: Assessment Director 2007

Search Committee: Director of Pharmaceutical Care Labs 2004

Search Committee: Pharmaceutical Policy and Evaluative Sciences

Chair 2004

Planning Committee: Inaugural Research Conference 2002

Other

Faculty Delegate, American Association of Colleges of Pharmacy 2004-05

Faculty Council 2008-11

Mentor Committee for Joel Farley, PhD 2006-Present

Consultation to faculty in area of measurement and data analysis 2002-Present

BLALOCK

27

PROFESSIONAL AFFILIATIONS

American Pharmaceutical Association

American Public Health Association

Association of Rheumatology Health Professionals

RESEARCH AND TEACHING INTERESTS

Risk communication

Falls prevention

Evaluation of health promotion and disease management programs

Health outcomes assessment

Patient decision-making and compliance with therapeutic regimens

Psychosocial aspects of chronic illness

Documents

SUSAN J. BLALOCK, Ph.D. Curriculum Vitae › wp-content › uploads › sites › ...Ferreri S, Roth MT, Casteel C, Demby KB, Blalock SJ. Methodology of an ongoing, randomized controlled